Europe Pharma Prepares for Tariffs

This is a U.S. news story, published by CNBC, that relates primarily to Donald Trump news.

U.S. news

For more U.S. news, you can click here:

more U.S. news

Donald Trump news

For more Donald Trump news, you can click here:

more Donald Trump news

News about health policy

For more health policy news, you can click here:

more health policy news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about

tariffs

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest tariff taskforces news, pharma imports news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

European pharmaceutical companies

CNBC

•

Health

'Tariff taskforce': Pharma firms scramble to prepare even as Trump levies risk flouting WTO rules

Summary

Nutrition label

82% Informative

Europe 's pharmaceutical firms are rushing to prepare for potential fallout of U.S. import duties.

President Donald Trump signaled that the EU could be next to face sweeping 25% tariffs.

Analysts warn that levies on drug makers could mark an infringement of rules set out by the World Trade Organization .

European pharmaceutical companies would be among the hardest hit by sweeping tariffs on the sector.

Others have warned that additional levies will only serve to push up costs in the already costly U.S. healthcare sector. "Many companies have a global supply chain, so in one way or another it will hurt either the companies or the patients, or other members of the quite complex U.S. health care system," Sydbank 's Lontoft said..

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful